1. Agid J., Javoy-Agid F., Ruberg M.:Biochemistry of neurotransmitters in Parkinson's disese. In: Marsden CD, Fahn S., Eds. Movement disorders, London, Butterworth. 116–230. 1987.
2. Ambanio C., Van Woert M.H., Murphy S.:Brain preoxidase and catalase in Parkinson's disease. Arch Neurol 32: 114–118, 1975.
3. Ballard P.A., Tetrud J.W., Langston J.W.:Permanent human parkinsonian due to 1-methyl-4-phenyl-1,25,6-tetrahydropyridine: seven cases. Neurology 35: 949–956, 1985.
4. Bankiewicz K.S., Oldfield E.H., Chieuh C.C., Doppman J.L., Jacobowitz D.M., Kopin I.J.:Hemiparkinsonism after unilateral infusion of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Life Sci. 39: 7–16, 1986.
5. Barbeau A., Poirier J., Dallaire L., Rucinksa E., Bu N.T., Donaldson J.:Studies on MPTP, MPP=, and paraquat in frogs and in vitro. In: Markey S.P., Castagnoli N., Trevor A., Kopin I.J., Eds. MPTP: a neurotoxin producing a parkinsonian syndrome. California: Academic Press, 23–42, 1986.